Philip Morris International has now entered North America with non-cigarette nicotine products. That's an area to which Altria is looking for growth, as it attempts to offset the declines it is ...

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this move aligns with its long-term strategy.

Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 3 includes Altria, Heico, Intel, Palantir, ...

However, Altria faces significant challenges in this transition, particularly from the rapid rise of illicit flavored disposable e-vapor products, which have seen a 45% increase in users over the ...

Altria (NYSE: MO) is a consumer staples giant ... with costly write-offs associated with investments in vaping and marijuana. A second attempt in the vaping sector, with the purchase of NJOY ...

(Bloomberg) -- Altria Group Inc. kicked off a plan to cut at least $600 million of costs over the next five years as the tobacco group maintained its outlook for the year. The maker of Marlboro ...

This is compounded by limited enforcement against illicit vape products and the introduction of IQOS by Philip Morris International in the US market, which could further erode Altria’s market share.